| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/29/2010 | EP2231708A1 Remedies for pemphigus containing anti fas ligand antobodies |
| 09/29/2010 | EP2231707A1 Anti mif antibodies |
| 09/29/2010 | EP2231706A1 Biokinetics of fast-clearing polypeptides |
| 09/29/2010 | EP2231705A2 Treatment of interstitial cystitis |
| 09/29/2010 | EP2231704A2 Hepatitis c virus antibodies |
| 09/29/2010 | EP2231703A1 Systems and methods for altering rates of enzymatic processes |
| 09/29/2010 | EP2231699A2 Vaccines for brucellosis |
| 09/29/2010 | EP2231696A2 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 09/29/2010 | EP2231187A1 Method of inhibition of leukemic stem cells |
| 09/29/2010 | EP2231183A2 Therapy of rituximab-refractory rheumatoid arthritis patients |
| 09/29/2010 | EP2231181A1 New vaccine for the treatment of mycobacterium related disorders |
| 09/29/2010 | EP2231177A1 Trophic factor for the treatment of retinal degenerative diseases |
| 09/29/2010 | EP1929034B1 Cancerous disease modifying antibodies |
| 09/29/2010 | EP1729803B1 Therapeutic use of anti-cs1 antibodies |
| 09/29/2010 | EP1651674B1 Ups as modifiers of the beta catenin pathway and methods of use |
| 09/29/2010 | EP1476120B1 Treatment methods using anti-cd22 antibodies |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | CN101849003A Novel GPIIIa gene |
| 09/29/2010 | CN101849001A Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 09/29/2010 | CN101848999A Anti-CD20 monoclonal antibodies |
| 09/29/2010 | CN101848998A Anti-EPHA2 antibody |
| 09/29/2010 | CN101848937A Molecules and methods for modulating complement component |
| 09/29/2010 | CN101848936A Production method |
| 09/29/2010 | CN101848935A Methods for selecting protease resistant polypeptides |
| 09/29/2010 | CN101848929A Streptococcus pneumoniae pilus antigens |
| 09/29/2010 | CN101845452A Prokaryotic expression vector of dihydroxyacetone kinase and construction method and applications thereof |
| 09/29/2010 | CN101845438A Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 09/29/2010 | CN101845097A Marine shellfish toxin monoclonal antibody preparation method |
| 09/29/2010 | CN101845096A Cu2<+> specific monoclonal antibody and preparation method thereof |
| 09/29/2010 | CN101845095A Method for preparing double yolk antibody of porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus |
| 09/29/2010 | CN101845094A Double-cross-linking chemical synthesis method of citrinin-protein-coupled antigen and preparation method of anti-citrinin monoclonal antibody |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101220096B Preparation and application of humanized anti-spasmotoxin monoclone antibody |
| 09/29/2010 | CN101175495B Anti-cancer compound combination |
| 09/29/2010 | CN101070345B Anti-prostate-specific-antigen PSA monoclone antibody and its use |
| 09/28/2010 | US7803922 Expression vector comprising nucleotide sequences coding cleavage enzyme for use in gene expression profiling |
| 09/28/2010 | US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease |
| 09/28/2010 | US7803917 detecting a rhesus monkey BCRP polypeptide in a sample; used as a hematopoietic stem cell marker |
| 09/28/2010 | US7803916 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 09/28/2010 | US7803915 Ati-TAT88 polypeptide antibody; Anticarcinogenic agent; expression vector containign a nucleic acid operably linked to control sequences recognized by a host cell transformed with the vector |
| 09/28/2010 | US7803914 use of citric acid buffers for suppressing cryoprecipitation of IgM at a pH range and salt concentration suitable for storing IgM |
| 09/28/2010 | US7803913 Identifying preferential immunoglobulins for use in treatment and prevention of infections and cell proliferative disorders via repeated screening of phage library |
| 09/28/2010 | US7803904 Mucosal vascular addressing and uses thereof |
| 09/28/2010 | US7803618 nucleic acid encoding an anti-EpCAM protein; binds human epithelial cell adhesion molecule; immunoglobulin light chain region modified to reduce immunogenicity; diagnosis, prognosis and treatment of cancer |
| 09/28/2010 | US7803615 Death domain containing receptor 5 |
| 09/28/2010 | US7803614 isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevent and treatment; immunotherapy |
| 09/28/2010 | US7803603 Nematode ATP synthase subunit E polypeptide |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803562 Method for screening human intestinal Npt2B modulatory agents |
| 09/28/2010 | US7803555 Determining the effect of a test compound on the binding interaction between a folate receptor and a folate receptor-binding fragment of a filovirus envelope glycoprotein; a compound that reduces binding is a candidate compound for slowing the progression of a filovirus, e.g., Ebola, mediated disease |
| 09/28/2010 | US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates |
| 09/28/2010 | US7803379 Tumour-specific animal proteins |
| 09/28/2010 | US7803378 Antigen imitating extracellular areas of membrane proteins of type III produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 09/28/2010 | US7803377 Anti-DLL4 antibodies and methods using same |
| 09/28/2010 | US7803376 Synergistic mixture of a blocking agent of an inhibitory receptor or stimulant of an activating receptor of natural killer cells and an antibody that can be bound by the CD16 antigen; efficiency is enhanced through the increase of the antibody-dependent cellular cytoxicity mechanism |
| 09/28/2010 | US7803373 Chemokine panec-1 antibodies |
| 09/28/2010 | US7803372 Mixture of anti-CEA (carcinogenicembryonic antigen) monoclonal antibody (MAb) or fragment and drug |
| 09/28/2010 | US7803371 Anti-VEGF antibody |
| 09/28/2010 | US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody. |
| 09/28/2010 | CA2544185C Method of detecting hepatitis c virus |
| 09/28/2010 | CA2422620C Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome p450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 09/28/2010 | CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/28/2010 | CA2323503C Novel physiological active peptide and its use |
| 09/28/2010 | CA2286288C Monoclonal antibody recognizing the n-glycolylated-galacotose-glucose sialic acid oligosaccharide in malignant tumors and composition that contains it |
| 09/28/2010 | CA2285746C Osteoprotegerin binding proteins and receptors |
| 09/28/2010 | CA2235866C Methods of treating established colitis using antibodies against il-12 |
| 09/28/2010 | CA2208783C Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 09/28/2010 | CA2188017C Cardiotrophin and uses therefor |
| 09/28/2010 | CA2153494C Novel parasitic helminth proteins |
| 09/27/2010 | CA2660622A1 Rig-i mutations and uses thereof in diagnostic and therapeutic virus-dependent immune applications |
| 09/23/2010 | WO2010108127A1 Bispecific anti-her antibodies |
| 09/23/2010 | WO2010108126A2 Reprogramming compositions and methods of using the same |
| 09/23/2010 | WO2010107752A2 Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 09/23/2010 | WO2010107500A1 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 09/23/2010 | WO2010107380A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions |
| 09/23/2010 | WO2010107120A1 Antibody and anti-periodontal disease composition containing antibody |
| 09/23/2010 | WO2010107110A1 Antibody constant region variant |
| 09/23/2010 | WO2010107109A1 Antibody constant region variant |
| 09/23/2010 | WO2010106788A1 Fertility test method, fertility test kit, polynucleotide, polypeptide and antibody |
| 09/23/2010 | WO2010106431A2 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof |
| 09/23/2010 | WO2010106180A2 Optimized fc variants |
| 09/23/2010 | WO2010106088A1 Reagents for the atherosclerotic coronary plaque and uses thereof |
| 09/23/2010 | WO2010106051A1 Btla antibodies and uses thereof |
| 09/23/2010 | WO2010105446A1 A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof |
| 09/23/2010 | WO2010105298A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof |
| 09/23/2010 | WO2010105290A1 Humanised antibodies with anti-tumour activity |
| 09/23/2010 | WO2010086512A3 Lactobacillus rhamnosus pilus polypeptides and methods for producing them |
| 09/23/2010 | WO2010081679A3 Antibodies against human epo receptor |
| 09/23/2010 | WO2010036959A3 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
| 09/23/2010 | WO2010031720A3 Novel antibody formulation |
| 09/23/2010 | WO2009142773A4 Multivalent fibronectin based scaffold domain proteins |
| 09/23/2010 | WO2009131702A9 Antibodies against fcrn and use thereof |
| 09/23/2010 | WO2009074634A3 Polypeptides, antibody variable domains & antagonists |
| 09/23/2010 | US20100242134 Methods and polynucleotides for improving plants |
| 09/23/2010 | US20100242126 Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms |
| 09/23/2010 | US20100240876 Replikins and methods of identifying replikin-containing sequences |
| 09/23/2010 | US20100240875 Antibodies That Specifically Bind to Reg IV |
| 09/23/2010 | US20100240874 Method for purifying cancer-specific proliferating cell nuclear antigen |
| 09/23/2010 | US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells |
| 09/23/2010 | US20100240872 ANTI-Muc 17 ANTIBODY |